Focused Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History

Focused Wealth Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-40	Closed	-$1.18K	–	898
2023 Q4	$1.18K	Hold	40	–	–	﹤0.01%	841
2023 Q3	$831	Hold	40	–	–	﹤0.01%	866
2023 Q2	$982	Hold	40	–	–	﹤0.01%	886
2023 Q1	$1.62K	Hold	40	–	–	﹤0.01%	816
2022 Q4	$1.8K	Hold	40	–	–	﹤0.01%	791
2022 Q3	$2K	Hold	40	–	–	﹤0.01%	786
2022 Q2	$2K	Hold	40	–	–	﹤0.01%	764
2022 Q1	$5K	Hold	40	–	–	﹤0.01%	684
2021 Q4	$6K	Hold	40	–	–	﹤0.01%	673
2021 Q3	$5K	Hold	40	–	–	﹤0.01%	724
2021 Q2	$4K	Hold	40	–	–	﹤0.01%	767
2021 Q1	$4K	Hold	40	–	–	﹤0.01%	756
2020 Q4	$4K	Hold	40	–	–	﹤0.01%	694
2020 Q3	$5K	Buy	+40	New	+$4.2K	﹤0.01%	615
2020 Q1	–	Sell	-200	Closed	-$12K	–	776
2019 Q4	$12K	Hold	200	–	–	﹤0.01%	482
2019 Q3	$12K	Hold	200	–	–	﹤0.01%	465
2019 Q2	$13K	Buy	+200	New	+$12.9K	﹤0.01%	485

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Focused Wealth Management's TNDM Position: Q1 2024 in Review

Focused Wealth Management sold out of Tandem Diabetes Care (TNDM) in Q1 2024, closing a stake of 40 shares — an estimated $1.18K sold.

Focused Wealth Management first reported a position in TNDM in Q2 2019 and held it in 17 quarters. The position peaked at $13K in Q2 2019. 291 funds tracked by Wall St. Rank hold TNDM as of Q1 2024.

Focused Wealth Management reported no remaining Tandem Diabetes Care position as of Q1 2024 after selling out during the quarter.
Focused Wealth Management sold 40 Tandem Diabetes Care shares in Q1 2024, an estimated $1.18K.
Focused Wealth Management first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 17 quarters.
Focused Wealth Management's Tandem Diabetes Care position peaked at $13K in Q2 2019.
291 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.